BACKGROUND: Inborn errors of IL-12/IL-23-IFNγ immunity underlie Mendelian susceptibility to mycobacterial diseases (MSMD), a group of immunodeficiencies characterized by a highly selective susceptibility to weakly virulent strains of mycobacteria, such as non-tuberculous mycobacteria (NTM) and bacillus Calmette-Guérin (BCG). Cutaneous mycobacterial infections are common in MSMD and may represent a red flag for this immunodeficiency. OBJECTIVES: We present a case series of four paediatric patients with MSMD, specifically with IFNγR1 and STAT1 deficiencies, and cutaneous NTM/BCG infections to increase awareness of this immunodeficiency, which may, in some cases, be intercepted by the dermatologist and thus timely referred to the immunologist. MATERIALS & METHODS: Clinical, laboratory and genetic investigations of the four paediatric patients with MSMD are presented. RESULTS: All four presented patients experienced early complications after BCG vaccination. Two patients suffered recurrent mycobacteriosis, one patient experienced delayed BCG reactivation, and one patient died of disseminated avian mycobacteriosis. The dermatological manifestation in these patients included destructive nasal ulcerations, scrofuloderma of various sites and lupus vulgaris. All patients had a normal basic immune phenotype. CONCLUSION: The presented cases demonstrate that NTM/BCG infections in otherwise seemingly immunocompetent patients should raise suspicion of MSMD. This is of utmost importance as specific therapeutic approaches, such as IFNγ treatment or haematopoietic stem cell transplantation, may be employed to improve the disease outcome.

Centre for Cardiovascular Surgery and Transplantation Brno Czech Republic

Department of Immunology 2nd Faculty of Medicine Charles University Prague Motol University Hospital Prague Czech Republic

Department of Paediatrics 1st Faculty of Medicine Charles University Prague Thomayer University Hospital Prague Czech Republic

Department of Pathology and Molecular Medicine 3rd Faculty of Medicine Charles University Prague Thomayer University Hospital Prague Czech Republic

National Institute of Child Tuberculosis and Respiratory Diseases Dolny Smokovec Slovakia

Zobrazit více v PubMed

Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Hum Genet. 2020;139:993–1000. doi: 10.1007/s00439-020-02120-y. PubMed DOI PMC

Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014;26:454. doi: 10.1016/j.smim.2014.09.008. PubMed DOI PMC

Taur PD, Gowri V, Pandrowala AA, et al. Clinical and molecular findings in mendelian susceptibility to mycobacterial diseases: experience from India. Front Immunol. 2021;12:426. doi: 10.3389/fimmu.2021.631298. PubMed DOI PMC

Escalonilla P, Esteban J, Soriano ML, et al. Cutaneous manifestations of infection by nontuberculous mycobacteria. Clin Exp Dermatol. 1998;23:214–21. doi: 10.1046/j.1365-2230.1998.00359.x. PubMed DOI

Franco-Paredes C, Marcos LA, Henao-Martínez AF, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2018;32(1):e00069–18. doi: 10.1128/CMR.00069-18. PubMed DOI PMC

Alcaide F, Esteban J. Cutaneous and soft skin infections due to non-tuberculous mycobacteria. Enferm Infecc Microbiol Clin. 2010;28:46–50. doi: 10.1016/S0213-005X(10)70008-2. PubMed DOI

Kumar SN, Prasad TS, Narayan PA, Muruganandhan J. Granuloma with langhans giant cells: an overview. J Oral Maxillofac Pathol. 2013;17(3):420. doi: 10.4103/0973-029X.125211. PubMed DOI PMC

Radomski N, Cambau E, Moulin L, Haenn S, Moilleron R, Lucas FS. Comparison of culture methods for isolation of nontuberculous mycobacteria from surface waters. Appl Environ Microbiol. 2010;76:3514. doi: 10.1128/AEM.02659-09. PubMed DOI PMC

Fonseca L, Moore D, Durier N. MTB culture and phenotypic drug susceptibility testing-methods inventory inventory of methods for mycobacterial culture and Phenotypic Drug Susceptibility Testing (DST) from the culture and phenotypic DST sub-group of the STOP TB Partnership New Diagnostics Working Group Main Tests at a glance solid media liquid media Egg-based Agar-based Automated Manual LJ Ogawa 7H107H11 1 BACTE C 460 MBBacT ALERT MGIT ESP II MGIT CRI MODS NRA Culture [Internet]. https://www.merck.com, 2011. [Accessed on 11/12/2021].

Mi Wi Y. Treatment of extrapulmonary nontuberculous mycobacterial diseases. Infect Chemother. 2019;51:245. doi: 10.3947/ic.2019.51.3.245. PubMed DOI PMC

Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med. 2015;36:91. doi: 10.1016/j.ccm.2014.11.002. PubMed DOI PMC

Döffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clinical Infec Dis. 2004;38:e10–4. doi: 10.1086/380453. PubMed DOI

Lee WI, Huang JL, Yeh KW, et al. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs) J Formos Med Assoc. 2011;110:750–8. doi: 10.1016/j.jfma.2011.11.004. PubMed DOI

Hermansen TS, Thomsen V, Lillebaek T, Ravn P. Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark. PLoS One. 2014;9:e93986. doi: 10.1371/journal.pone.0093986. PubMed DOI PMC

Casanova JL. Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc Natl Acad Sci U S A. 2015;112:E7128–37. doi: 10.1073/pnas.1521651112. PubMed DOI PMC

Tovo PA, Garazzino S, Saglio F, et al. Successful hematopoietic stem cell transplantation in a patient with complete IFN-γ receptor 2 deficiency: a case report and literature review. J Clin Immunol. 2020;40:1191–5. doi: 10.1007/s10875-020-00855-x. PubMed DOI PMC

Falkinham JO. Ecology of nontuberculous mycobacteria. Microorganisms. 2021;9:2262. doi: 10.3390/microorganisms9112262. PubMed DOI PMC

Wentworth AB, Drage LA, Wengenack NL, Wilson JW, Lohse CM. Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study. Mayo Clin Proc. 2013;88:38. doi: 10.1016/j.mayocp.2012.06.029. PubMed DOI PMC

Dolezalova K, Maly M, Wallenfels J, Gopfertova D. Nontuberculous mycobacterial infections in children in the Czech Republic in the period 2003–2018. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021;165:277–82. doi: 10.5507/bp.2020.025. PubMed DOI

Elston D. Nontuberculous mycobacterial skin infections: recognition and management. Am J Clin Dermatol. 2009;10:281–5. doi: 10.2165/00128071-200910050-00001. PubMed DOI

Li JJ, Beresford R, Fyfe J, Henderson C. Clinical and histopathological features of cutaneous nontuberculous mycobacterial infection: a review of 13 cases. J Cutan Pathol. 2017;44:433–43. doi: 10.1111/cup.12903. PubMed DOI

Bruijnesteijn Van Coppenraet ES, Lindeboom JA, Prins JM, Peeters MF, Claas ECJ, Kuijper EJ. Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children. J Clin Microbiol. 2004;42:2644. doi: 10.1128/JCM.42.6.2644-2650.2004. PubMed DOI PMC

Kim YN, Kim KM, Choi HN, et al. Clinical usefulness of PCR for differential diagnosis of tuberculosis and nontuberculous mycobacterial infection in paraffin-embedded lung tissues. J Mol Diagn. 2015;17:597–604. doi: 10.1016/j.jmoldx.2015.04.005. PubMed DOI

Lindeboom JA, Kuijper EJ, Prins JM, Bruijnesteijn Van Coppenraet ES, Lindeboom R. Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis. 2006;43:1547–51. doi: 10.1086/509326. PubMed DOI